CABLIVI
As listed in the register: CABLIVI 10 mg, poudre et solvant pour solution injectable
10 mg · poudre et solvant pour solution injectable
- Prescription only
- Active substance
- Caplacizumab
- Made by
- ABLYNX (BELGIQUE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
Spain1 matching products
Netherlands1 matching products
Details
| Made by | ABLYNX (BELGIQUE) |
|---|---|
| Active substance | Caplacizumab |
| Strength | 10 mg |
| Form | poudre et solvant pour solution injectable |
| Route | intraveineuse;sous-cutanée |
| Dispensing (as stated by the register) | prescription hospitalière · liste I |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/18/1305 |
| Name in the register | CABLIVI 10 mg, poudre et solvant pour solution injectable |
| Packs | 1 flacon en verre de 10 mg - 1 seringue préremplie en verre de 1 ml avec adaptateur pour flacon avec aiguille hypodermique avec 2 tampons alcoolisés · 7 (7x1) flacons en verre de 10 mg - 7 (7x1) seringues préremplies en verre de 1 ml avec 7 (7x1) adaptateurs pour flacon, 7 (7x1) aiguilles hypodermiques (30G), 14 (7x2) tampons imbibés d’alcool (Boite multidose) |
| CIS | 64183564 |
| CIP13 | 3400930155110 |
| CIP13 | 3400930172759 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).